ArticleBMC plant biology2026
Secondary volatile metabolite content of two Echi̇nacea species in two subsequent years in Ri̇ze, Türki̇ye.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The present research aimed to determine the secondary volatile metabolite composition of E. angustifolia and E. purpurea under the ecological conditions of Pazar/Rize over two years. Both species were investigated over two consecutive years and their secondary volatile metabolite profiles of the aboveground plant parts (totally stems, leaves, flowers, and inflorescences of 40 plants per plot) were determined using GC-MS analysis supported with SPME in triplicate. Remarkable variation could be detected between the two species. Major components detected in E. angustifolia in both years (2015–2016) were p Cymene (35.24% and 21.36%), β –Pinene (23.32% and 16.74%) and α – Pinene (11.23% and 8.09). On the other hand, main components obtained in E. purpurea in both years were Caryophyllene oxide (12.61 and 15.13%), Germacrene D (8.15% and 15.12%) and Allo-Aromadendrene (15.01% and 0.00%).The combined results indicated that E. angustifolia and E. purpurea cultivated in Rize exhibited secondary volatile metabolite compositions that differed in concentration from those previously reported in the literature.Several important secondary volatile metabolite components were detected in E. angustifolia and E. purpurea during both years of the study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.